Tenax Therapeutics Inc <TENX.O>: Leerink Partners cuts target price to $4 from $26
TENX•Related News
IHS Towers Q2 FY26 turns to IFRS net loss of USD 7.5 million; revenue from continuing operations rises 10.4% to USD 428.6 million
IHS•
California Resources Corporation <CRC.N>: Barclays cuts target price to $77 from $80
CRC•
Concentra Group Holdings Parent, Inc. <CON.N>: Wells Fargo raises target price to $40 from $28
CON•
BlackRock reports 5.19% stake in Heidelberg Materials
BLK•
Insurers, Spirax drag down UK's FTSE 100 index
SPY•